TRPC6 and myocardial ischemia: Hypertrophic cardiomyopathy and cardiac failure are caused by the overexpression of TRPC6 [60], and the inhibition of its expression ameliorates cardiac fibrosis and myocardial ischemia–reperfusion injury [61, 62].